Antipodes Partners’s Sempra SRE Stock Holding History
Bought
Maintained
Sold
Other funds holding SRE
PL
OTPPB
Antipodes Partners's SRE Position: Q2 2026 in Review
Antipodes Partners increased its Sempra (SRE) stake by 2.9% in Q2 2026, buying an estimated $4.72M and bringing the position to 1,773,357 shares worth $164M. The position accounts for 3.01% of the portfolio, ranked #8.
Antipodes Partners first reported a position in SRE in Q3 2025 and has held it in 4 quarters since. The position peaked at $167M in Q1 2026. 771 funds tracked by Wall St. Rank hold SRE as of Q2 2026.
- Antipodes Partners held 1,773,357 shares of Sempra worth $164M as of Q2 2026.
- Antipodes Partners bought 50,765 Sempra shares in Q2 2026, an estimated $4.72M.
- Sempra made up 3.01% of Antipodes Partners's portfolio in Q2 2026, its #8 holding.
- Antipodes Partners first reported a position in Sempra in Q3 2025 and has held it in 4 quarters since.
- Antipodes Partners's Sempra position peaked at $167M in Q1 2026.
- 771 funds tracked by Wall St. Rank held Sempra as of Q2 2026.
Based on Antipodes Partners's 13F filing for Q2 2026, filed 6 Aug 2026.